Everolimus Tablet
Product Images NDC 63850-0107

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 63850-0107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Everolimus 0 25mg Bottle Label

FDA Label Image

Carton (Everolimus 0 25mg Carton)

This is a package insert for Everolimus tablets manufactured by Natco Pharma Limited in India. The tablets contain 0.25mg of the drug and the dosage information can be found in the insert. It is important to keep this medication away from children and to store it at temperatures between 15°C-30°C (59°F-86°F). The medication should also be protected from light and moisture. Side effects should be reported to a doctor or to the FDA.*

FDA Label Image

Foil (Everolimus 0 25mg Foil)

This is a list of medications containing Everolimus Tablets of 0.25mg and 0.26mg. These tablets are manufactured by Natco Pharma Ltd and are used to treat certain types of cancer. The batch numbers and expiry dates of the tablets are also provided for reference.*

FDA Label Image

Everolimus 0 5mg Bottle Label

FDA Label Image

Carton (Everolimus 0 5mg Carton)

This is a package insert for Everolimus tablets in a dosage of 0.5mg per tablet. It includes a warning to keep the medication out of children's reach, instructions for storage temperatures, and a reminder to call a doctor if experiencing side effects. The manufacturer is Natco Pharma Limited in India, and the tablets come in a carton of 60 tablets, with 6 blister cards of 10 tablets each. The NDC number for this medication is 63850-0063-2.*

FDA Label Image

Foil (Everolimus 0 5mg Foil)

This text seems to be a list of details about the Everolimus Tablet, 0.5 mg, manufactured by Natco Pharma Ltd., which includes information like the HDC code, NDC code, date of issue, and batch number. However, some of the text is unreadable due to being cut off or unrecognized characters, so it is difficult to determine the complete information.*

FDA Label Image

Everolimus 0 75mg Bottle Label

FDA Label Image

Carton (Everolimus 0 75mg Carton)

The text is a medication label for Everolimus Tablets, manufactured by Natco Pharma Limited in India. The recommended dosage is provided in the package insert, and it is advised to keep the medication out of the reach of children and protected from light and moisture. The tablets contain 0.75 mg per tablet and are packed in a carton with six individual blister cards of ten tablets each. The NDC number for the tablets is 63850-0064-2. Patients should call their doctor for medical advice about side effects and can report side effects to FDA at 1-800-FDA-1088.*

FDA Label Image

Foil (Everolimus 0 75mg Foil)

This is a list of several pharmaceutical products identified by their National Drug Codes (NDCs) and manufacturers. The products are Evarolimus and Everolimus Tablets, which come in different strengths (0.75 mg and 0.76 mg). The manufacturers are Nateo Pharma Ltd. and Natco Pharma Ltd. The products have different lot numbers, and some of them come with expiration dates. There is no further information about these pharmaceutical products.*

FDA Label Image

Everolimus-fig-1 (Everolimus Fig 1)

This is a table showing the €GFR (MDRD 4) values in mL/min/1.73m^2 for different visit windows and treatment groups. The treatment groups include EVR+Reduced TAC, A&~ TAC, and TAC Control. The values range from 60 to 110 mL/min/1.73m^2.*

FDA Label Image

Everolimus Chemical Structure (Everolimus Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.